CAPRICOR THERAPEUTICS, INC. — Form D

CAPRICOR THERAPEUTICS, INC. of BEVERLY HILLS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-12-05. The offering totals $26.3M, of which $26.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Anthony DaviesExecutive OfficerBeverly Hills, CA
Andrew HamerExecutive OfficerOakville, A6
Joshua KazamDirectorNew York, NY
Hsiao D LieuExecutive OfficerSouth San Francisco, CA
David M TanenDirectorNew York, NY
David M TanenExecutive OfficerNew York, NY
Arie S BelldegrunDirectorNew York, NY
George DunbarDirectorAnn Arbor, MI
Daron EvansExecutive OfficerSouth Orange, NJ
Frank M LitvackDirectorPalo Alto, CA
Frank LitvackDirectorMENLO PARK, CA
Deborah AscheimExecutive OfficerBEVERLY HILLS, CA
Leland GershellExecutive OfficerBEVERLY HILLS, CA
Earl CollierDirectorBEVERLY HILLS, CA
Louis ManzoDirectorBEVERLY HILLS, CA
Rachel SmithExecutive OfficerBEVERLY HILLS, CA
Karen KrasneyExecutive OfficerBEVERLY HILLS, CA
Linda MarbanDirectorBEVERLY HILLS, CA
Linda MarbanExecutive OfficerBEVERLY HILLS, CA
David MusketDirectorBEVERLY HILLS, CA
Anthony BergmannExecutive OfficerBEVERLY HILLS, CA
Louis GrasmickDirectorBeverly Hills, CA
Gregory SchaferDirectorBeverly Hills, CA
Earl Collier, Jr.DirectorBeverly Hills, CA
Gregory W SchaferDirectorBerkeley, CA

Other filings by this issuer (7)

FiledFormOfferingSold
2017-05-19D$3.7M$3.7M
2016-03-29D$14K$14K
2015-02-19D$7.1M$7.1M
2015-02-03D$10.0M$10.0M
2014-02-24D$33K$33K
2011-06-27D$2.5M$2.5M
2009-07-15D$3.0M$2.3M

More